354 related articles for article (PubMed ID: 21685220)
1. Is surgery indicated in patients with stage IIIa lung cancer and mediastinal nodal involvement?
Bakir M; Fraser S; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 Sep; 13(3):303-10. PubMed ID: 21685220
[TBL] [Abstract][Full Text] [Related]
2. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
3. In patients undergoing lung resection for non-small cell lung cancer, is lymph node dissection or sampling superior?
Hughes MJ; Chowdhry MF; Woolley SM; Walker WS
Interact Cardiovasc Thorac Surg; 2011 Sep; 13(3):311-5. PubMed ID: 21606053
[TBL] [Abstract][Full Text] [Related]
4. Does surgery have a role in T4N0 and T4N1 lung cancer?
Chambers A; Routledge T; Billè A; Scarci M
Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):473-9. PubMed ID: 20621998
[TBL] [Abstract][Full Text] [Related]
5. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?
Chamogeorgakis T; Ieromonachos C; Georgiannakis E; Mallios D
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):364-72. PubMed ID: 18641014
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
Tieu BH; Sanborn RE; Thomas CR
Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
[TBL] [Abstract][Full Text] [Related]
7. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
[TBL] [Abstract][Full Text] [Related]
8. Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases.
Maggi G; Casadio C; Cianci R; Molinatti M; Filosso PL; Nicolosi M; Oliaro A
Int Surg; 1993; 78(3):213-7. PubMed ID: 8276543
[TBL] [Abstract][Full Text] [Related]
9. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
10. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
11. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
12. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
14. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
15. Operative results of non-small cell lung cancer clinically presenting mediastinal lymph adenopathy.
Yoshino I; Yamaguchi M; Yohena T; Kameyama T; Kometani T; Osoegawa A; Maehara Y
Fukuoka Igaku Zasshi; 2003 Aug; 94(8):250-8. PubMed ID: 14579727
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
[TBL] [Abstract][Full Text] [Related]
17. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
18. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
Zhang GQ; Han F; Gao SL; A DL; Pang ZL
Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
[TBL] [Abstract][Full Text] [Related]
19. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
[TBL] [Abstract][Full Text] [Related]
20. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
Cerfolio RJ; Bryant AS; Minnich DJ
Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
